Answers are grounded in this paper and cite their sources.
Dr. Michael Bober is a PI for A Prospective Natural History Study of Patients with Rhizomelic Chondrodysplasia Punctata, sponsored by Med-Life Discoveries LP. Dr. Michael Bober, Dr. Nancy Braverman, and Dr. Poll-Thé are also members of Medical Advisory Board for RhizoKids International. The other authors have no conflict of interest to declare. The data that support the findings of this study are available from the corresponding author upon reasonable request.
No takes yet. Share an insight, caveat, or question.
Duker et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: